Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05426954 · ClinicalTrials.gov registry record · NA
BFRT MPFL and ACL Reconstruction Rehab
A NA study of Anterior Cruciate Ligament Reconstruction Rehabilitation and Medial Patellar Femoral Ligament Reconstruction Rehabilitation, sponsored by Richard Watson, PT.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
- 1
- Study location
NCT05426954: Completed NA study of Anterior Cruciate Ligament Reconstruction Rehabilitation and Medial Patellar Femoral Ligament Reconstruction Rehabilitation, sponsored by Richard Watson, PT.
NCT05426954 is a NA study of Anterior Cruciate Ligament Reconstruction Rehabilitation and Medial Patellar Femoral Ligament Reconstruction Rehabilitation that has completed, run by Richard Watson, PT. The registered enrollment target is 43 participants, above the 37-participant average among 4 other Anterior Cruciate Ligament Reconstruction Rehabilitation trials with a reported enrollment target (16% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05426954, a NA study of Anterior Cruciate Ligament Reconstruction Rehabilitation and Medial Patellar Femoral Ligament Reconstruction Rehabilitation, has completed, sponsored by Richard Watson, PT.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
Blood flow restrictive (BFR) therapy following MPFL or ACL reconstruction rehabilitation. Specific Aim 1: Test whether maintaining BFR cuff inflation or deflating between exercises results in greater quadriceps strength and functional outcomes after MPFL or ACL reconstruction. Hypothesis 1: Subjects in the deflate BFR protocol group will have significantly greater quadriceps strength, symmetric leg symmetry index on a battery of functional tests and PROs as compared to the non-deflate group. Specific Aim 2: Compare whether maintaining BFR cuff inflation or deflating between exercises results in reduced pain, improved exercise tolerance, and patient-reports outcomes (PRO) after MPFL or ACL reconstruction. Hypothesis 2: Subjects in the deflated BFR protocol group will report significantly less pain and greater exercise tolerance during exercise with significantly improved knee related PRO scores.
Primary Outcome
involved vs uninvolved isometric quadriceps knee strength measured at 90 degrees flexion comparison
Conditions Studied
Interventions
- OTHER Rehabilitation utilizing blood flow restrictive therapy
Study Locations (1)
Kentucky
- University of Kentucky Sports Rehabilitation - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2021-06-29 |
| Est. Completion | 2023-07-28 |
| Phase | NA |
What the finished NCT05426954 record still lists
NCT05426954 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, above the 37-participant average among 4 other Anterior Cruciate Ligament Reconstruction Rehabilitation trials with a reported enrollment target (16% higher).
The record links to 2 conditions, with Anterior Cruciate Ligament Reconstruction Rehabilitation appearing as the primary indexed condition, and to 1 intervention - of which Rehabilitation utilizing blood flow restrictive therapy is the first listed.
NCT05426954 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT05426954 about?
NCT05426954 is a clinical study titled "BFRT MPFL and ACL Reconstruction Rehab". Blood flow restrictive (BFR) therapy following MPFL or ACL reconstruction rehabilitation. Specific Aim 1: Test whether maintaining BFR cuff inflation or deflating between exercises results in greater quadriceps strength and functional outcomes after MPFL or ACL reconstruction. Hypothesis 1: Subjec...
What is the current status of trial NCT05426954?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2021-06-29. Estimated completion is 2023-07-28.
What conditions does trial NCT05426954 study?
This clinical trial studies the following conditions: Anterior Cruciate Ligament Reconstruction Rehabilitation, Medial Patellar Femoral Ligament Reconstruction Rehabilitation.
What interventions are being tested in trial NCT05426954?
The interventions under investigation include: Rehabilitation utilizing blood flow restrictive therapy (OTHER).
Who is sponsoring clinical trial NCT05426954?
This trial is sponsored by Richard Watson, PT, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05426954 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anterior Cruciate Ligament Reconstruction Rehabilitation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Anterior Cruciate Ligaments: Studying Updates in neuroCognition After Knee Manipulation
RECRUITING · NA
-
ACL Reconstruction Rehabilitation With Exercise and Psychological Support
RECRUITING · NA
-
Evaluation of Home-based Telerehabilitation Platform to Augment Orthopedic Rehabilitation
RECRUITING · NA
-
Determining the Effects of Non-invasive Brain Stimulation to Improve Quadriceps Muscle Function After ACL Reconstruction
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI